$4.14 Billion is the total value of Alphabet Inc.'s 67 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 34.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PATH | Sell | UiPath Inccl a | $606,781,000 | -34.4% | 14,068,674 | -20.0% | 14.65% | -33.2% |
| VERV | Verve Therapeutics Inc | $404,612,000 | -21.6% | 10,974,011 | 0.0% | 9.77% | -20.2% | |
| DXCM | Sell | Dexcom Inc | $378,026,000 | -14.2% | 704,011 | -12.6% | 9.13% | -12.7% |
| New | IonQ Inc | $365,848,000 | – | 21,907,038 | +100.0% | 8.83% | – | |
| New | Toast Inccl a | $329,637,000 | – | 9,496,884 | +100.0% | 7.96% | – | |
| New | EQRX Inc | $324,309,000 | – | 47,552,687 | +100.0% | 7.83% | – | |
| LYFT | Lyft Inc | $262,283,000 | -20.3% | 6,138,154 | 0.0% | 6.33% | -18.8% | |
| New | Planet Labs PBC | $196,445,000 | – | 31,942,641 | +100.0% | 4.74% | – | |
| OSCR | Oscar Health Inccl a | $188,736,000 | -54.9% | 24,042,864 | 0.0% | 4.56% | -54.1% | |
| Benson Hill Inc | $107,544,000 | +2.2% | 14,752,271 | 0.0% | 2.60% | +4.1% | ||
| New | Freshworks Inc | $105,975,000 | – | 4,035,595 | +100.0% | 2.56% | – | |
| RCUS | Sell | Arcus Biosciences Inc | $103,742,000 | -27.4% | 2,563,441 | -37.5% | 2.50% | -26.1% |
| Sell | Robinhood Mkts Inc | $87,531,000 | -73.0% | 4,928,535 | -36.0% | 2.11% | -72.5% | |
| DM | Desktop Metal Inc | $54,691,000 | -31.0% | 11,048,730 | 0.0% | 1.32% | -29.7% | |
| RLAY | Sell | Relay Therapeutics Inc | $48,036,000 | -7.2% | 1,564,173 | -4.7% | 1.16% | -5.5% |
| LYEL | Lyell Immunopharma Inc | $45,396,000 | -47.7% | 5,865,125 | 0.0% | 1.10% | -46.8% | |
| ME | New | 23andMe Holding Co | $44,867,000 | – | 6,736,785 | +100.0% | 1.08% | – |
| SANA | Sana Biotechnology Inc | $43,538,000 | -31.3% | 2,812,500 | 0.0% | 1.05% | -30.1% | |
| Adagio Therapeutics Inc | $41,242,000 | -82.8% | 5,680,785 | 0.0% | 1.00% | -82.5% | ||
| New | Science 37 Holdings Inc | $40,416,000 | – | 3,241,075 | +100.0% | 0.98% | – | |
| GLUE | Monte Rosa Therapeutics Inc | $29,895,000 | -8.3% | 1,464,015 | 0.0% | 0.72% | -6.7% | |
| BEAM | Beam Therapeutics Inc | $25,629,000 | -8.4% | 321,604 | 0.0% | 0.62% | -6.8% | |
| RAPT | Sell | RAPT Therapeutics Inc | $23,058,000 | +4.6% | 627,762 | -11.6% | 0.56% | +6.5% |
| ILMN | Illumina Inc | $20,342,000 | -6.2% | 53,470 | 0.0% | 0.49% | -4.7% | |
| New | Enjoy Technology Inc | $20,076,000 | – | 4,345,340 | +100.0% | 0.48% | – | |
| KRON | Kronos Bio Inc | $19,546,000 | -35.2% | 1,438,232 | 0.0% | 0.47% | -34.0% | |
| VERA | Sell | Vera Therapeutics Inccl a | $19,069,000 | +16.3% | 713,658 | -24.5% | 0.46% | +18.3% |
| VACC | Sell | Vaccitech PLCads | $18,935,000 | -29.4% | 1,704,344 | -0.0% | 0.46% | -28.1% |
| IDYA | Ideaya Biosciences Inc | $17,805,000 | -7.3% | 753,187 | 0.0% | 0.43% | -5.5% | |
| Tenaya Therapeutics Inc | $17,353,000 | -8.2% | 915,705 | 0.0% | 0.42% | -6.7% | ||
| Sell | Duolingo Inc. | $15,327,000 | -87.1% | 144,444 | -79.7% | 0.37% | -86.8% | |
| MGTA | Magenta Therapeutics Inc | $14,792,000 | -39.2% | 3,339,138 | 0.0% | 0.36% | -38.1% | |
| SPRO | Spero Therapeutics Inc | $14,249,000 | -13.0% | 889,979 | 0.0% | 0.34% | -11.6% | |
| FHTX | Foghorn Therapeutics Inc | $11,456,000 | +64.2% | 500,901 | 0.0% | 0.28% | +66.9% | |
| Amplitude Inc | $10,029,000 | -2.6% | 189,447 | 0.0% | 0.24% | -0.8% | ||
| NEWR | New Relic Inc | $10,021,000 | +53.2% | 91,132 | 0.0% | 0.24% | +56.1% | |
| DBTX | Decibel Therapeutics Inc | $7,609,000 | -39.7% | 1,636,258 | 0.0% | 0.18% | -38.5% | |
| TSHA | Taysha Gene Therapies Inc | $7,466,000 | -37.4% | 640,882 | 0.0% | 0.18% | -36.4% | |
| S | New | Sentinelone Inccl a | $6,993,000 | – | 138,503 | +100.0% | 0.17% | – |
| OMIC | Sell | Singular Genomics Systems Inc | $6,781,000 | -6.3% | 586,584 | -9.3% | 0.16% | -4.7% |
| New | Hyperfine Inc | $6,516,000 | – | 898,720 | +100.0% | 0.16% | – | |
| EVLO | Evelo Biosciences Inc | $6,437,000 | -13.8% | 1,060,495 | 0.0% | 0.16% | -12.4% | |
| Tscan Therapeutics Inc | $4,847,000 | -46.0% | 1,077,080 | 0.0% | 0.12% | -45.1% | ||
| FULC | Fulcrum Therapeutics Inc | $4,519,000 | -37.3% | 255,452 | 0.0% | 0.11% | -36.3% | |
| ALEC | Alector Inc | $3,632,000 | -9.5% | 175,866 | 0.0% | 0.09% | -7.4% | |
| AUTL | Autolus Therapeutics PLCspon adr | $3,624,000 | -20.8% | 698,262 | 0.0% | 0.09% | -19.3% | |
| NVTA | Invitae Corp | $3,300,000 | -46.3% | 215,965 | 0.0% | 0.08% | -45.2% | |
| CRTX | Cortexyme Inc | $2,387,000 | -86.2% | 189,122 | 0.0% | 0.06% | -85.9% | |
| UBER | Uber Technologies Inc | $2,074,000 | -6.4% | 49,466 | 0.0% | 0.05% | -5.7% | |
| OPRT | New | Oportun Finl Corp | $1,919,000 | – | 94,788 | +100.0% | 0.05% | – |
| EXAS | Exact Sciences Corp | $1,806,000 | -18.5% | 23,205 | 0.0% | 0.04% | -17.0% | |
| TWLO | Twilio Inccl a | $994,000 | -17.5% | 3,776 | 0.0% | 0.02% | -17.2% | |
| SQZ | SQZ Biotechnologies Co | $928,000 | -38.1% | 103,929 | 0.0% | 0.02% | -38.9% | |
| New | Nextdoor Holdings Inc | $768,000 | – | 97,391 | +100.0% | 0.02% | – | |
| CMPX | New | Compass Therapeutics Inc | $611,000 | – | 192,794 | +100.0% | 0.02% | – |
| New | WeWork Inccl a | $547,000 | – | 63,645 | +100.0% | 0.01% | – | |
| SPGI | S&P Global Inc | $279,000 | +10.7% | 592 | 0.0% | 0.01% | +16.7% | |
| RGEN | New | Repligen Corp | $101,000 | – | 383 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 10-Q | 2024-04-26 |
| 144 | 2024-04-26 |
| 4 | 2024-04-26 |
| 4 | 2024-04-26 |
| ARS | 2024-04-26 |
| DEF 14A | 2024-04-26 |
| DEFA14A | 2024-04-26 |
| 8-K | 2024-04-25 |
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.